Skip to main content
Caplight Logo









Transdermal Diagnostics

Transdermal Diagnostics

Private
BristolHealthcare & Life Scienceshttps://transdermal-diagnostics.com/

Last Round

Accelerator

Sep 18, 2025

Total Funding Raised

$2.27M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Transdermal Diagnostics is a medical technology company that develops a wearable, needle-free continuous glucose monitoring device for the management of diabetes and other chronic conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2C

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

continuous glucose monitoringCGMneedle-freenon-invasive glucose monitorwearable diagnostic devicediabetes managementsmart patchinterstitial fluid sensingmedical wearabledigital healthhealth IoTbloodless glucose testmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Transdermal Diagnostics Comparables

Compare Transdermal Diagnostics with similar companies based on industry and business-model similarity.

Transdermal Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Afon Technology
88%
One Health Biosensing Inc.
85%
GlucoModicum
84%

Transdermal Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 18, 2025
GrantFeb 4, 2025
SeedSep 6, 2022
GrantSep 6, 2022

Key People

Founding team and executive leadership

Luca Lipani

Co-Founder & CEO

Founding Team

Transdermal Diagnostics Investors

Notable investors and investment history

Transdermal Diagnostics investors
InvestorRounds
QUBISSeed
SBRI HealthcareGrant
Health Innovation NetworkGrant
Pioneer GroupSeed
Bristol Private Equity ClubSeed
ImmetricSeed
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2025

    Received funding from University of Edinburgh AI Accelerator.

  • May 3, 2025

    Monthly visitors increased 36% MoM, reaching 417.

Transdermal Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Transdermal Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Transdermal Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBristol
Employee Range10
Year Founded2021
Last FundingSep 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?